格林国际控股2026年中期财报:营收2,506万元

公告速递
Sep 30

本期信息

截至2026年6月30日,格林国际控股录得营收约2,506万元,同比2025年同期的2,818万元下降约11.06%,主要由于今年上半年缺少美容及健身业务相关收入贡献。公告显示,毛利约为1,411万元,相较去年同期的1,928万元下降约26.82%,毛利率约为56.30%,低于去年同期的68.43%。期内,销售费用约为498.1万元,同比下降约26.78%;行政开支约915.1万元,同比下降约9.24%。报告期内,经营活动所得现金净额约159.2万元。

业务分项

格林国际控股主要从事保健及医疗服务和美容及健身两方面业务。保健及医疗业务包括血液透析中心及医院医疗服务,受惠于既有医院搬迁带来的产能提升,回顾期内收入维持增长。美容及健身业务此前在中国深圳以“瑪莎(Marsa)”品牌经营多家美容院,但于上年已部分关闭或出售相关资产,因此本期间无明显业务贡献。

高管解读

俞周杰(主席):“本人谨代表董事会,感谢本集团全体股东、客户、供应商及银行的持续支持;本人对全体员工在本期间恪尽职守及所作出的贡献深表赞赏。”

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10